Sustainability in Injection Pens: Why Recycling & Circular Programs Are Becoming a New Competitive Advantage

Disposable injection pens have enabled millions of people to self-administer therapies safely at home—but they also create a growing environmental challenge. As GLP-1, insulin, and other injectable therapies expand worldwide, the industry is taking sustainability far more seriously. Today, recycling and circular-economy programs for disposable pens are moving from “nice to have” to a differentiator—increasingly discussed by pharmaceutical brands, pharmacies, and healthcare systems.

This SEO blog explains why pen recycling is gaining momentum, what leading programs look like, and what manufacturers and brands can do to build more sustainable injection-pen ecosystems.

1) Why Sustainability Is Becoming a Hot Topic in the Injection-Pen Industry

The scale of disposable pen waste is growing

Many prefilled pens are made largely from plastic and mixed materials. In Japan, a Novo Nordisk recycling pilot described prefilled pens as being approximately 77% plastic—materials that have historically been incinerated or landfilled after use.

As GLP-1 adoption increases globally, the number of pens used each month rises, and waste management becomes a visible issue for:

• pharmacies and clinics (collection and safety)

• healthcare systems (waste handling costs)

• brands (ESG targets and public expectations)

• distributors (tender requirements increasingly include sustainability criteria)

2) The New “Circular” Model: Real-World Pen Recycling Programs

A) UK: Novo Nordisk’s PenCycle (pharmacy + mail-back returns)

In the UK, Novo Nordisk’s PenCycle program allows patients to return eligible empty prefilled pens (with needles removed) via participating community pharmacies and mail-back options. Reporting from The Pharmaceutical Journal noted:

• ~200,000 pens returned since launch (as of August 2023)

• ~2 tonnes of plastic waste saved

• thousands of pharmacies registered with the scheme

The same publication also described the program’s return-box format (e.g., boxes that hold multiple pens) and that materials are recycled into new products.

B) Denmark: Nationwide pharmacy return schemes

Denmark implemented a nationwide return scheme where insulin-pen users can return used pens at pharmacies. A city partnership update described a pilot return rate near 20% (about 77,000 pens) before nationwide rollout.

C) Japan: ReMed pilot for used prefilled injection pens

In Japan, a pilot called ReMed began trial operations in select regions, collecting used prefilled pens via designated pharmacies and recycling the plastic into new materials/products.

Why these programs matter: They show that recycling is not just a concept—it’s becoming operational through pharmacy-led take-back, mail-back logistics, and specialized processing.

3) Why “Standard Retail Recycling” Usually Doesn’t Work for Used Pens

Used injection pens are medical items. Many general retail recycling schemes exclude medical devices for safety reasons. For example, Boots’ consumer recycling scheme lists medical devices as excluded items.

That’s why pen recycling typically requires:

• needle removal before return (sharps safety)

• dedicated return packaging and instructions

• controlled handling and processing routes

4) What Makes Injection Pens Hard to Recycle

Unlike simple plastic packaging, pens often include:

• multiple plastic types

• metal springs and drive components

• glass cartridges/syringe elements (depending on design)

• adhesives, inks, and coatings

This mixed-material construction complicates recycling unless the program is designed around:

• safe collection

• separation/disassembly

• reliable downstream processing partners

5) The Sustainability Toolkit: What Brands & Manufacturers Can Do

5.1 Design for circularity (DfC)

If you’re developing a pen platform, sustainability improvements often start with engineering decisions:

• reduce unnecessary mixed materials where possible

• simplify disassembly (fewer steps, fewer bonded parts)

• favor recyclable polymers and consistent material families

• minimize coatings or inks that interfere with recycling streams

5.2 Build “take-back” into the patient journey

Successful programs make returns convenient:

• pharmacy drop-off during routine visits

• mail-back boxes/pouches with clear instructions

• simple rules (e.g., remove needles; return empty device)

PenCycle’s approach—pharmacy integration + mail-back logistics—illustrates how convenience drives participation.

5.3 Improve packaging footprint too

Sustainability is not only about the device. Secondary packaging can be redesigned to reduce plastics and CO₂ footprint. For example, SCHOTT Pharma and partners presented a “blister-free syringe” packaging concept reporting improved pallet density and reduced CO₂ impact in a case study.

6) What This Means for Procurement and B2B Partnerships

Sustainability is increasingly becoming part of vendor selection. Buyers may evaluate:

• evidence of a recycling or take-back program (where applicable)

• packaging reduction initiatives

• traceability and safe disposal messaging

• scalability of circular workflows across markets

In other words: a credible sustainability story can support brand trust and purchasing decisions, especially for large distributors and healthcare procurement teams.

7) Key Takeaways

• The surge in GLP-1 and biologic therapies is increasing disposable pen volumes—and the waste conversation.

• Pharmacy-led recycling schemes like PenCycle and national return programs show circular models can work at scale.

• General retail recycling channels often exclude medical devices, so dedicated programs are essential.

• The next competitive edge combines device design, take-back logistics, and packaging footprint reduction.